Scott H. Okuno
Department of Oncology
Mayo Clinic College of Medicine
Rochester
Minnesota
Name/email consistency: high
- A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: A study of the Mayo phase 2 consortium (P2C). Okuno, S., Bailey, H., Mahoney, M.R., Adkins, D., Maples, W., Fitch, T., Ettinger, D., Erlichman, C., Sarkaria, J.N. Cancer (2011)
- A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021. Okuno, S.H., Delaune, R., Sloan, J.A., Foster, N.R., Maurer, M.J., Aubry, M.C., Rowland, K.M., Soori, G.S., Nikcevich, D.A., Kardinal, C.G., Northfelt, D.W., Adjei, A.A. Cancer (2008)
- Mammalian target of rapamycin inhibitors in sarcomas. Okuno, S. Curr. Opin. Oncol (2006)
- The enigma of desmoid tumors. Okuno, S. Curr. Treat. Options. Oncol (2006)
- Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium. Okuno, S., Maples, W.J., Mahoney, M.R., Fitch, T., Stewart, J., Fracasso, P.M., Kraut, M., Ettinger, D.S., Dawkins, F., Erlichman, C. J. Clin. Oncol. (2005)
- Combination chemotherapy for desmoid tumors. Okuno, S.H., Edmonson, J.H. Cancer (2003)
- Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group. Okuno, S., Ryan, L.M., Edmonson, J.H., Priebat, D.A., Blum, R.H. Cancer (2003)
- Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno, S.H., Mailliard, J.A., Suman, V.J., Edmonson, J.H., Creagan, E.T., Nair, S., Levitt, R., Kugler, J.W. Cancer (2002)
- Small cell lung cancer: current therapy and promising new regimens. Okuno, S.H., Jett, J.R. Oncologist (2002)
- Phase II trial of gemcitabine in advanced sarcomas. Okuno, S., Edmonson, J., Mahoney, M., Buckner, J.C., Frytak, S., Galanis, E. Cancer (2002)